EC Number   |
Expression |
Reference |
|---|
   2.1.1.319 | down |
PRMT1 mRNA content in the denervated soleus muscle decreases by 32% and 37% as compared with the control muscle after 6 and 12 h, respectively |
755764 |
| 2.1.1.319 | down |
relative to the control muscle, PRMT4 mRNA expression levels in the denervated soleus muscle is decreased by 31% after 12 h |
755764 |
| 2.1.1.319 | down |
the GATA transcription factor elt-2 is a positive regulator of Pprmt-1:: gfp expression. elt-2 RNAi decreases endogenous PRMT-1 expression at mRNA and protein levels |
757115 |
| 2.1.1.319 | down |
two splice variants of PRMT1 (variants v.1 and v.2) are downregulated in breast cancer |
756861 |
| 2.1.1.319 | up |
expression levels is highly increased after induction of encystation from 24-72 h |
757532 |
| 2.1.1.319 | up |
expression of PRMT1 mRNA and protein content are significantly induced in skeletal muscle cells during the phenotypic remodeling elicited by myogenesis |
756228 |
| 2.1.1.319 | up |
following 72 h and 168 h of denervation, PRMT1 protein content increases 3.6-5fold |
755764 |
| 2.1.1.319 | up |
H2O2 treatment increases isoforms PRMT1 and PRMT4 expression but decreases sirtuin SIRT1 expression. Similar to H2O2 treatment, PRMT1 or PRMT4 overexpression increases retinal pigment epithelial cell damage |
734831 |
| 2.1.1.319 | up |
PRMT4 mRNA content increases 2.3fold or 1.7fold in the denervated muscle compared with the control muscle after 72 and 168 h of denervation, respectively |
755764 |
| 2.1.1.319 | up |
protein arginine N-methyltransferase 1 expression is significantly upregulated in hepatocellular carcinoma cell lines and clinical tissues |
758525 |
